Not applicableUnknownNCT05821790What this trial is testingRole of the Tumor Microenvironment in Aggressive MeningiomasWho this might be right forMeningioma Assistance Publique - Hôpitaux de Paris 40
Early research (Phase 1)Active Not RecruitingNCT06104488What this trial is testingAvutometinib for People With Solid Tumor CancersWho this might be right forRefractory CancerCNS TumorsCNS Tumor, Adult+12 more Memorial Sloan Kettering Cancer Center 3
Early research (Phase 1)Ended earlyNCT05228015What this trial is testingOral TEAD Inhibitor Targeting the Hippo Pathway in Subjects with Advanced Solid TumorsWho this might be right forSolid Tumors, AdultSolid TumorMalignant Pleural Mesothelioma (MPM)+5 more Ikena Oncology 67
Very early researchEnded earlyNCT02282917What this trial is testingExploratory Evaluation of AR-42 Histone Deacetylase Inhibitor in the Treatment of Vestibular Schwannoma and MeningiomaWho this might be right forVestibular SchwannomaMeningiomaAcoustic Neuroma+1 more Massachusetts Eye and Ear Infirmary 7
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07713745What this trial is testingPlatform Research for Innovative Medicines in NF2-SWN (PRIME-NF2)Who this might be right forNeurofibromatosis Type 2Vestibular SchwannomaNon-vestibular Schwannoma+4 more Beijing Tiantan Hospital 200
Not applicableEnded earlyNCT01736267What this trial is testingAuditory Brainstem Implant (ABI) in Adult Non-Neurofibromatosis Type 2 SubjectsWho this might be right forBilateral Hearing Loss for Causes Other Than Tumors Massachusetts Eye and Ear Infirmary 3
Not applicableStudy completedNCT03210285What this trial is testingWES of NF2-associated in Comparison to Sporadic Vestibular Schwannomas - Correlation With Clinical DataWho this might be right forNeurofibromatosis Type 2Vestibular SchwannomaAcoustic Neuroma University Hospital Tuebingen 70
Not applicableStudy completedNCT01222728What this trial is testingUsing Positron Emission Tomography to Predict Intracranial Tumor Growth in Neurofibromatosis Type II PatientsWho this might be right forNeoplasmsNervous System DiseaseVestibular Disease National Institute of Neurological Disorders and Stroke (NINDS) 5
Testing effectiveness (Phase 2)Study completedNCT01024946What this trial is testingEverolimus (RAD001) for the Treatment of Malignant Pleural Mesothelioma With Merlin/NF2 Loss as a Biomarker to Predict SensitivityWho this might be right forMalignant Pleural Mesothelioma Memorial Sloan Kettering Cancer Center 11
Early research (Phase 1)WithdrawnNCT01850225What this trial is testingFeasibility Study of Auditory Brainstem Implant in Young ChildrenWho this might be right forBilateral Cochlear AplasiaBilateral Cochlear Nerve DeficiencyBilateral Cochlear Ossification Secondary to Meningitis House Research Institute
Not applicableEnded earlyNCT01864291What this trial is testingAuditory Brainstem Implant (ABI) in Pediatric Non-Neurofibromatosis Type 2 SubjectsWho this might be right forBilateral Hearing Loss for Causes Other Than Tumors Massachusetts Eye and Ear Infirmary 9
Not applicableNot Yet RecruitingNCT07818213What this trial is testingHow Can the Experience of Hospital Outpatient Departments be Improved?Who this might be right forNeurofibromatosis Type 1 (NF1)NF2-related Schwannomatosis King's College London 30
Not applicableUnknownNCT05685836What this trial is testing89Zr-Bevacizumab PET/CT Imaging in NF2 PatientsWho this might be right forNeurofibromatosis 2 Leiden University Medical Center 15
Not applicableUnknownNCT00004483What this trial is testingNF2 Natural History ConsortiumWho this might be right forSchwannoma, VestibularNeurofibromatosis 2Meningioma House Ear Institute 100
Early research (Phase 1)Ended earlyNCT01552434What this trial is testingBevacizumab and Temsirolimus Alone or in Combination With Valproic Acid or Cetuximab in Treating Patients With Advanced or Metastatic Malignancy or Other Benign DiseaseWho this might be right forAdvanced Malignant NeoplasmCastleman DiseaseDigestive System Carcinoma+36 more M.D. Anderson Cancer Center 154
Early research (Phase 1)Looking for participantsNCT05873686What this trial is testingClinical Study of NXP900 in Subjects With Advanced CancersWho this might be right forAdvanced Solid TumorNSCLC (Non-small Cell Lung Cancer)Renal Cancer+3 more Nuvectis Pharma, Inc. 140
Testing effectiveness (Phase 2)Study completedNCT01419639What this trial is testingPhase II Study of Everolimus (RAD001) in Children and Adults With Neurofibromatosis Type 2Who this might be right forNeurofibromatosis Type II NYU Langone Health 10
Not applicableStudy completedNCT02246231What this trial is testingEffect of Implant Position on Magnetic Resonance Image DistortionWho this might be right forNeurofibromatosis Type 2 Manchester University NHS Foundation Trust 5
Testing effectiveness (Phase 2)Active Not RecruitingNCT04439331What this trial is testingTesting VS-6063 (Defactinib) as a Potential Targeted Treatment in Cancers With NF2 Genetic Changes (MATCH-Subprotocol U)Who this might be right forAdvanced LymphomaAdvanced Malignant Solid NeoplasmHematopoietic and Lymphoid Cell Neoplasm+3 more National Cancer Institute (NCI) 35
Testing effectiveness (Phase 2)Study completedNCT01125046What this trial is testingBevacizumab in Treating Patients With Recurrent or Progressive MeningiomasWho this might be right forAcoustic SchwannomaAdult Anaplastic MeningiomaAdult Ependymoma+7 more Northwestern University 50